10074-A4 (C09-1102-143)

10074-A4 is a c-Myc inhibitor. 10074-A4 could bind to c-Myc 370-409 at different sites along the peptide chain. 10074-A4 has anticancer effects.In Vitro10074-A4 shows inhibitory activity of HL-60 cells with an IC 50 of 15.1 μM. 10074-A4 (25-50 μM; 24 hours) arrests the cell cycle at the S-phase in a dose-dependent manner in HL-60 cells. 10074-A4 inhibits the mRNA level of the c-Myc target genes, CCND2 and CDK4. 10074-A4 could bind to c-Myc 370-409 at different sites along the peptide chain and its binding behavior could be described as a ‘ligand cloud’. Even in the bound state, the structure of the c-Myc 370-409 peptide remained a dynamic ensemble. The 10074-A4 ligand bound at different sites throughout the c-Myc 370-409 chain with different strength. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: HL-60 cells Concentration: 25 μM, 50 μM Incubation Time: 24 hours Result: Arrested the cell cycle at the S-phase.Form:Solid. Specification: 0.98 Molecular Formula: C18H14Cl2N2O3S Molecular Weight: 409.29 PubChem CID: 2836204 Isomeric SMILES: C1C(=O)N(C(=O)S1)CC(CN2C3=C(C=C(C=C3)Cl)C4=C2C=CC(=C4)Cl)O